Boston Partners’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-353,488
Closed -$3.44M 768
2018
Q3
$3.44M Sell
353,488
-5,760
-2% -$61.1K ﹤0.01% 529
2018
Q2
$3.96M Sell
359,248
-606,101
-63% -$6.26M ﹤0.01% 511
2018
Q1
$10.1M Sell
965,349
-346,630
-26% -$3.68M 0.01% 384
2017
Q4
$14.7M Sell
1,311,979
-184,220
-12% -$2.09M 0.02% 349
2017
Q3
$17.6M Buy
1,496,199
+72,270
+5% +$857K 0.02% 329
2017
Q2
$18M Buy
1,423,929
+221,911
+18% +$2.66M 0.02% 328
2017
Q1
$13.5M Buy
1,202,018
+148,757
+14% +$1.66M 0.02% 363
2016
Q4
$11.7M Buy
1,053,261
+108,750
+12% +$1.22M 0.02% 391
2016
Q3
$11.1M Buy
+944,511
New +$11M 0.02% 390

Other funds holding MRT

Boston Partners's MRT Position: Q4 2018 in Review

Boston Partners sold out of MedEquities Realty Trust, Inc. (MRT) in Q4 2018, closing a stake of 353,488 shares — an estimated $3.44M sold.

Boston Partners first reported a position in MRT in Q3 2016 and held it in 9 quarters. The position peaked at $18M in Q2 2017. 95 funds tracked by Wall St. Rank hold MRT as of Q4 2018.

  • Boston Partners reported no remaining MedEquities Realty Trust, Inc. position as of Q4 2018 after selling out during the quarter.
  • Boston Partners sold 353,488 MedEquities Realty Trust, Inc. shares in Q4 2018, an estimated $3.44M.
  • Boston Partners first reported a position in MedEquities Realty Trust, Inc. in Q3 2016 and held it in 9 quarters.
  • Boston Partners's MedEquities Realty Trust, Inc. position peaked at $18M in Q2 2017.
  • 95 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q4 2018.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.